TORONTO, Oct. 17, 2019 /CNW/ - 48North Cannabis Corp.
("48North" or the "Company") (TSXV:NRTH) is pleased to announce
that it has signed an exclusive licensing agreement with U.S.-based
APCNA Holdings LLC. ("Apothecanna"), to bring its best-selling,
premium cannabis topicals brand to Canadian consumers.
Apothecanna, an established U.S cannabis brand focused on
organic topical formulations, made without the use of artificial
ingredients, fillers, parabens, or GMO ingredients, has been a
leading topicals brand in the United
States since its founding in 2009. Apothecanna has developed
a suite of next-generation health and wellness cannabis products
including, but not limited to: pain relief creams, a skincare line,
sex oils, and other therapeutic cannabis-based topicals.
48North is focused on delivering best-in-class and innovative
next-generation cannabis products to Canadian consumers. To that
end, the Company strongly believes that value-added cannabis
products that have succeeded in mature U.S markets, will also
succeed in the Canadian marketplace. The agreement with
Apothecanna, on the heels of the Company's previously announced
licensing agreements with Avitas and Mother & Clone, builds on
48North's growing portfolio of popular U.S-based cannabis
brands.
"Without question, Apothecanna is one of the leading topical
cannabis brands in the United
States. Since 2009, Apothecanna has led the charge in
combatting cannabis stigma through spreading the wisdom of
traditional plant medicine. They have successfully formulated a
suite of best-in-class health and wellness products and developed
an industry-leading brand. We are so excited to announce that
Apothecanna's products will soon be available for Canadian
consumers," said Alison Gordon, CEO
of 48North.
"Great partnerships require shared values, and, like us, 48North
is all about innovation and performance. Their commitment to
sustainability and all-natural ingredients gave us the confidence
we needed to expand our business into Canada. We look forward to combining our
formulations and expertise with 48North's high-quality outdoor
cannabis with the vision of normalizing cannabis through sport with
the help of Good:Farm and 48North," said James Kennedy, Founder and CEO, of
Apothecanna.
Under the terms of the licensing agreement signed October 16, 2019, 48North will license
Apothecanna intellectual property and manufacturing techniques for
domestic consumption in Canada.
These products will be produced and marketed in accordance with
applicable Canadian laws and regulations for the adult-use
recreational cannabis market.
About 48North
48North Cannabis Corp. (TSXV: NRTH) is a vertically integrated
cannabis company focused on the health and wellness market through
cultivation and extraction, as well as the creation of innovative,
authentic brands for next-generation cannabis products. 48North is
developing formulations and manufacturing capabilities for its own
proprietary products, as well as positioning itself to contract
manufacture similar products for third parties. 48North operates
Good:Farm, a 100-acre organic cannabis farm that is expected to
produce more than 40,000 kg of organic, sun-grown cannabis,
securing a significant first-mover advantage in the production of
low-cost, next-generation, extract-based cannabis products. In
addition, 48North operates two indoor-licensed cannabis production
sites in Ontario. 48North
cultivates unique genetics at its wholly owned subsidiary, DelShen
Therapeutics Corp. ("delshen") and processes cannabis and
manufactures next-generation cannabis products at Good & Green
Corp. ("Good & Green"), both Licensed Producers under the
Cannabis Act. 48North has a growing portfolio of brands that
include Latitude, a women's cannabis platform
(explorelatitude.com); Mother & Clone, a rapid-acting
sublingual cannabis nanospray (momandclone.com); Avitas, a
single-strain vaporizer cartridge (avitasgrown.com) and Quill, a
leader in the manufacturing of beautifully designed,
lifestyle-focused and sleek vape products (quill.me).
About Apothecanna
Apothecanna, a true innovator in the US cannabis space that is
focused on high performance topicals, has been a leader in
the United States cannabis market
since its founding in 2009. Apothecanna's formulas blend
all-natural, premium plant-based extracts that are created without
the use of artificial ingredients, fillers, parabens, or GMO
ingredients. Apothecanna has developed a range of next-generation
cannabis products including pain relieving and calming creams and
oils that are focused on enhancing performance by complimenting
active lifestyles and recovery routines.
DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release. Certain statements contained in this press release
constitute forward-looking information. These statements relate to
future events or future performance. The use of any of the words
"could," "intend," "expect," "believe," "will," "projected,"
"estimated" and similar expressions and statements relating to
matters that are not historical facts are intended to identify
forward-looking information and are based on the parties' current
beliefs or assumptions as to the outcome and timing of such future
events. Actual future results may differ materially. Please refer
to the Company's SEDAR filings for further details concerning the
risks associated with the Company's business. The forward-looking
information contained in this release is made as of the date hereof
and the parties are not obligated to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise, except as required by
applicable securities laws. Because of the risks, uncertainties and
assumptions contained herein, investors should not place undue
reliance on forward-looking information. The foregoing statements
expressly qualify any forward-looking information contained
herein.
SOURCE 48North Cannabis Corp.